Maes Piet, Clement Jan, Van Ranst Marc
Clinical Virology, Rega Institute for Medical Research, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B3000 Leuven, Belgium.
Expert Rev Vaccines. 2009 Jan;8(1):67-76. doi: 10.1586/14760584.8.1.67.
Rodent-borne hantaviruses are associated with two main clinical disorders in humans: hemorrhagic fever with renal syndrome and hantavirus cardiopulmonary syndrome. Although hantavirus diseases can be life threatening and numerous research efforts are focused on the development of hantavirus prevention, no specific antiviral therapy is yet available and, at this time, no WHO-approved vaccine has gained widespread acceptance. This review will summarize the current knowledge and recent progress as well as new speculative approaches in the development of hantavirus vaccines.
肾综合征出血热和汉坦病毒心肺综合征。尽管汉坦病毒疾病可能危及生命,并且众多研究工作都集中在汉坦病毒预防的开发上,但目前尚无特效抗病毒疗法,且尚无获得世界卫生组织批准的疫苗得到广泛认可。本综述将总结汉坦病毒疫苗开发的当前知识、最新进展以及新的推测性方法。